RxDoctor Payments Data

Anne Sutherland, MD

Family Medicine · Troutdale, ORNPI 1609824051

Payments from drug & device makers

$1,643in general payments, 2019–2025

Across 97 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$228
  • Pfizer$225
  • Boehringer Ingelheim$124
  • GSK$106
  • Johnson & Johnson$84
  • Teva Pharmaceuticals USA, Inc.$78
  • plus $797 from 22 others

What the payments were for

  • Food & beverage$1,47890%
  • Education$16510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,643 in reported general payments places this provider in the 90th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$49,706
Medicare patients
141
Services billed
744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$104,954
OzempicSemaglutide81$104,204
EliquisApixaban93$89,644
JardianceEmpagliflozin64$66,330
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$64,294
TrulicityDulaglutide32$33,953
MyrbetriqMirabegron47$24,666
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$11,188
EntrestoSacubitril/Valsartan15$10,604
Aimovig AutoinjectorErenumab-Aooe12$10,357
Spiriva RespimatTiotropium Bromide12$10,315
Fluticasone-SalmeterolFluticasone Propion/Salmeterol46$7,491
Varenicline Tartrate26$6,164
Tresiba Flextouch U-100Insulin Degludec14$5,884
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$104,20481 claims
PfizerEliquis$225$89,64493 claims
Boehringer IngelheimJardiance, Spiriva Respimat$124$76,64576 claims
GSKTrelegy Ellipta, Anoro Ellipta$106$75,48290 claims
Lilly USA, LLCTrulicity$40$33,95332 claims
Astellas Pharma US IncMyrbetriq$228$24,66647 claims
NovartisEntresto$61$10,60415 claims
Hikma Pharmaceuticals USABuprenorphine Hcl$15$1,45018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Troutdale

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →